Efavirenz-induced exfoliative dermatitis.
Scand J Infect Dis
; 45(1): 70-2, 2013 Jan.
Article
in En
| MEDLINE
| ID: mdl-22715849
ABSTRACT
Individuals with a human immunodeficiency virus (HIV) infection are at higher risk of developing adverse drug reactions. Multiple drugs are usually prescribed to patients with HIV infection for preventing the replication of HIV and for the treatment of the associated opportunistic infections. We report here the first case of an HIV-1-infected patient who developed an exfoliative dermatitis induced by efavirenz, a non-nucleoside reverse transcriptase inhibitor. Physicians should be aware of the possible occurrence of efavirenz-induced skin eruptions from the start of antiviral treatment of HIV infection.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Dermatitis, Exfoliative
/
Anti-HIV Agents
/
Benzoxazines
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Scand J Infect Dis
Year:
2013
Document type:
Article
Affiliation country: